Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall
- 1 November 1983
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 32 (4), 355-363
- https://doi.org/10.1016/0049-3848(83)90088-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Heparin cofactor activities in a family with hereditary antithrombin III deficiency: evidence for a second heparin cofactor in human plasmaBlood, 1983
- A sensitive competitive binding assay for exogenous and endogenous heparinsThrombosis Research, 1982
- Uptake and inhibition of thrombin by the vascular wallThrombosis Research, 1982
- Activation of Protein C In VivoJournal of Clinical Investigation, 1982
- Identification in vitro of an endothelial cell surface cofactor for antithrombin III. Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium.Journal of Clinical Investigation, 1982
- Detection of a new heparin-dependent inhibitor of thrombin in human plasma.Journal of Clinical Investigation, 1981
- Clearance of Thrombin from Circulation in Rabbits by High-affinity Binding Sites on EndotheliumJournal of Clinical Investigation, 1980
- Inhibition of thrombin on surfaces coated with immobilized heparin and heparin-like polysaccharides: A crucial non-thrombogenic principleThrombosis Research, 1980
- Inhibition of thrombin by antithrombin III in the presence of certain glycosaminoglycans found in the mammalian aortaThrombosis Research, 1978